MammoSite^®

References

• Hebert-Croteau N, Bisson J, Latreille J et al. Compliance with consensus recommendation for the treatment of early stage breast carcinoma elderly women. Cancer 85, 1104–1113 (1999).
   PubMed Web of Science ®Google Scholar
• Athas WF, Adams-Cameron M, Hunt WC et al. Travel distance to radiation therapy and receipt of radiotherapy following breast conserving surgery. J. Natl Cancer Inst. 92, 269–271 (2000).
   PubMedGoogle Scholar
• Nattinger AB, Hoffmann RG, Kneusel RT et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast conserving surgery. Lancet 356, 1148–1153 (2000).
   PubMed Web of Science ®Google Scholar
• Baxter NN, Virnig BA, Durham SB et al. Trends in the treatment of ductal carcinoma in situ of the breast. J. Natl Cancer Inst. 96, 443–448 (2004).
   PubMedGoogle Scholar
• Veronesi U, Marubini E, Mariani L et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of randomized trial. Ann. Oncol. 12, 997–1003 (2001).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Kestin L, Chen P et al. Limited-field radiation therapy in the management of early-stage breast cancer. J. Natl Cancer Inst. 95, 1205–1211 (2003).
   PubMedGoogle Scholar
• Cuttino LW, Arthur DW, Todor DA et al. CT-guided multi-catheter insertion technique for partial breast brachytherapy (PBB): reliable target coverage and dose homogeneity. Brachytherapy 2, 41–68 (2003).
   Google Scholar
• Arthur D, Vicini F, Kuske RR et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy 1(4), 184–190 (2002).
   PubMedGoogle Scholar
• Vicini FA, Baglan KL, Kestin LL et al. Accelerated treatment of breast cancer. J. Clin. Oncol. 19, 1993–2001 (2001).
   PubMed Web of Science ®Google Scholar
• Keisch M, Vicini F, Kuske RR et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 55(2), 289–293 (2003).
   PubMed Web of Science ®Google Scholar
• Harper J, Jenrette J, Vanek KN et al. Acute complications of MammoSite brachytherapy: a single institution’s initial clinical experience. Int. J. Radiat. Oncol. Biol. Phys. 61(1), 169–174 (2005).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Beitsch P, Quiet C et al. First analysis of patient demographics and technical reproducibility by the American Society of Breast Surgeons (ASBS) MammoSite breast brachytherapy registry trial in 801 patients treated with accelerated partial breast irradiation (APBI). Abstract San Antonio Breast Cancer Symposium (2004).
   Google Scholar
• Edmundson GK, Vicini FA, Chen PY et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int. J. Radiat. Oncol. Biol. Phys. 52(4), 1132–1139 (2002).
   PubMed Web of Science ®Google Scholar
• Dickler A, Kirk M, Choo J et al. Treatment volume and dose optimization of the MammoSite™ breast brachytherapy applicator. Int. J. Radiat. Oncol. Biol. Phys. 59, 469–474 (2004).
   PubMed Web of Science ®Google Scholar
• Keisch M, Vicini F, Scroggins T et al. Thirty month results with the MammoSite breast brachytherapy applicator: cosmesis, toxicity and local control in partial breast irradiation. Int. J. Radiat. Oncol. Biol. Phys. 60(1), S272 (2004).
   Google Scholar
• Vicini FA, Kestin L, Chen P et al. Limited-field radiation therapy in the management of early-stage breast cancer. J. Natl Cancer Inst. 95(16), 1205–1210 (2003).
   PubMedGoogle Scholar
• Baglan KL, Martinez AA, Frazier RC et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 50(4), 1003–1011 (2001).
   PubMed Web of Science ®Google Scholar
• Vicini FA, Baglan KL, Kestin LL et al. Accelerated treatment of breast cancer. J. Clin. Oncol. 19(7), 1993–2001 (2001).
   PubMed Web of Science ®Google Scholar
• Polgar C, Sulyok Z, Fodor J et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: 5-year results of a Phase I-II study and initial findings of a randomized Phase III trial. J. Surg. Oncol. 80(3), 121–128 (2002).
   PubMed Web of Science ®Google Scholar
• King TA, Bolton JS, Kuske RR et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am. J. Surg. 180(4), 299–304 (2000).
   PubMed Web of Science ®Google Scholar
• Fentiman IS, Poole C, Tong D et al. Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur. J. Cancer 27(4), 447–450 (1991).
   PubMed Web of Science ®Google Scholar
• Fentiman IS, Poole C, Tong D et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur. J. Cancer 32A(4), 608–611 (1996).
   PubMed Web of Science ®Google Scholar
• Kuske RR. Breast brachytherapy. Hematol. Oncol. Clin. North Am. 13(3), 543–547 (1999).
   PubMed Web of Science ®Google Scholar
• Wazer DE, Lowther D, Boyle T et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 50(1), 107–111 (2001).
   PubMed Web of Science ®Google Scholar
• Cionini L, Pacini P, Marzano S. Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon Chir. 89, 128 (1993).
   Google Scholar
• Krishnan L, Jewell WR, Tawfik OW et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J. 7(2), 91–96 (2001).
   PubMedGoogle Scholar
• Wazer DE, Berle L, Graham R et al. Preliminary results of a Phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 53(4), 889–897 (2002).
   PubMed Web of Science ®Google Scholar
• Kuske RR, Bolton JS. A Phase I/II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma. Radiation Therapy Oncology Group Publication no. 1055. Radiation Therapy Oncology Group, PA, USA (1995).
   Google Scholar
• Perera F, Yu E, Engel J et al. Patterns of breast reoccurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with 6 years’ minimum follow up. Int. J. Radiat. Oncol. Biol. Phys. 57(5), 1239–1246 (2003).
   PubMed Web of Science ®Google Scholar
• Clarke DH, Vicini FA, Jacobs H et al. High dose rate brachytherapy for breast cancer. In: High Dose Rate Brachytherapy: A Textbook. Nag S (Ed.). Futura Publishing Company, Inc., NY, USA, 321–329 (1994).
   Google Scholar
• Tobias JS, Vaidya JS, Keshtgar M et al. Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. Br. J. Radiol. 77, 279 (2004).
   PubMed Web of Science ®Google Scholar
• Vaidya JS, Tobias JS, Baum M et al. Intraoperative radiotherapy for breast cancer. Lancet Oncol. 5, 165 (2004).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Gatti G, Luini A et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch. Surg. 138, 1253 (2003).
   PubMedGoogle Scholar
• Vicini FA, Remouchamps V, Wallace M et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 57(5), 1247–1253 (2003).
   PubMed Web of Science ®Google Scholar
• Formenti SC, Truong MT, Goldberg JD et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys. 60(2), 493–504 (2004).
   PubMed Web of Science ®Google Scholar
• Richards GM, Berson AM, Rescigno J et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann. Surg. Oncol. 11(8), 739–746 (2004).
   PubMed Web of Science ®Google Scholar
• Shah NM, Tenenholz T, Arthur D et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101(4), 727–734 (2004).
   PubMed Web of Science ®Google Scholar